Bausch + Lomb Co. (NYSE:BLCO – Get Free Report)’s stock price reached a new 52-week low during trading on Thursday after ...
Stifel lowered the firm’s price target on Bausch + Lomb (BLCO) to $15 from $17 and keeps a Hold rating on the shares. Following last week’s ...
Wells Fargo & Company reiterated their equal weight rating on shares of Bausch + Lomb (NYSE:BLCO – Free Report) in a report issued on Friday morning, MarketBeat.com reports. They currently have a $15.
Stocks sold off Friday, pressured by growing uncertainty on U.S. trade policy as well as a more grim outlook on inflation.
Here are some of the top stories moving markets midday Friday. The "Magnificent Seven" are part of the reason stocks are ...
Wells Fargo downgraded Bausch + Lomb Corp to Equal Weight from Overweight on uncertainty from the voluntary recall of its enVista intraocular lenses (IOLs), which is expected to weigh on sales growth, ...
Bausch + Lomb (NYSE:BLCO) stock falls as the company's voluntary recall of enVista lenses leads to a downgrade at Wells Fargo ...
Deutsche Bank slashed the price target for Tesla, Inc. TSLA from $420 to $345. Deutsche Bank analyst Edison Yu maintained a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results